Astellas Announces FDA Approval of ASTAGRAF XL(TM) (tacrolimus extended ... Wall Street Journal ... Administration (FDA) has approved ASTAGRAF XL(TM) (tacrolimus extended-release capsules) for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without ... |
